Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
In the video, Shelley, a 70-year-old diagnosed with acute myeloid leukemia after her chronic myelomonocytic leukemia progressed, shares her cancer journey and how participating in a clinical trial…
Martin Lee, author of Smoke Signals, and director of Project CBD, discusses the results of a University of Calgary study that found New Yorkers suffering from PTSD after the…
Nancy Simonian, MD, CEO, Syros Pharmaceuticals explains that by modulating components of super-enhancers, important genes that drive disease states may be able to be turned down. She references a recent…
Martin Lee, author of Smoke Signals, and director of Project CBD, discusses the enlightening research coming out of the California Pacific Medical Center about the antitumor and anticancer effects of cannabinoids.…
NEW YORK (Reuters Health) – While pancreatic cancer mortality is still higher among blacks than whites in the US, rates are decreasing among blacks and increasing among whites,…
NEW YORK (Reuters Health) – In the neoadjuvant treatment of HER2-positive breast cancer, administering trastuzumab concurrently with anthracyclines offers no advantage over sequential administration, according to the results…
NEW YORK (Reuters Health) – Compared to single-agent platinum chemotherapy, platinum-combination chemotherapy improves survival in patients with recurrence of ovarian cancer, a meta-analysis has shown. The researchers say…
NEW YORK (Reuters Health) – Results of a randomized trial conducted in Italy indicate that conventional external radiotherapy (RT) after breast conserving surgery for early breast cancer is…
NEW YORK (Reuters Health) – In hospitalized cancer patients, the common problem of hyponatremia can be corrected by administration of the orally active V2 receptor antagonist, tolvaptan. The…
Martin Lee, author of Smoke Signals, and director of Project CBD, explains his motivations for pursuing cannabinoid research and his interest in the social history of marijuana. He explains the challenge…
By Will Boggs, MD NEW YORK (Reuters Health) –In mice, treatment with tumor necrosis factor (TNF) or lymphotoxin makes the blood-brain barrier (BBB) selectively permeable at metastasis sites,…
